Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended Post-operative Oral TXA vs. Standard Perioperative TXA in Primary TJA
NCT07685743Phase 4Not yet recruiting
- Sponsor
- Oregon Health & Science University
- Start
- Sep 2026
- Primary completion
- Mar 2028
01
Overview
Phase 4, randomised, double-blind trial in osteoarthritis (OA) comparing Extended Oral TXA with Placebo (2 arms). Primary endpoint: Knee injury and Osteoarthritis Outcome Score for Joint Replacement or Hip injury and Osteoarthritis Outcome Score for Joint Replacement at 6 weeks. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07685743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07685743.